XOMA Royalty (XOMA) Net Equity Issued and Repurchased (2010 - 2019)
XOMA Royalty (XOMA) reported Net Equity Issued and Repurchased of $22.0 million for Q4 2019, up 489.04% on a YoY basis from $3.7 million in Q4 2018, and up 489.04% sequentially from $3.7 million in Q4 2018.
XOMA Royalty (XOMA) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends
XOMA Royalty (XOMA) has 10 years of Net Equity Issued and Repurchased data on file, last reported at $22.0 million in Q4 2019.
- For the quarter ending Q4 2019, Net Equity Issued and Repurchased rose 489.04% year-over-year to $22.0 million; the trailing twelve-month figure through Sep 2020 stood at $25.7 million (up 585.0% YoY), and the FY2025 full-year result was $323000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased grew to $22.0 million in Q4 2019, from $3.7 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $22.0 million in Q4 2019 to a low of -$189000.0 in Q4 2015.
- A 5-year average of $4.4 million and a median of $134000.0 in 2015 frame the typical range for Net Equity Issued and Repurchased.
- Across the five-year window, Net Equity Issued and Repurchased slumped 100.5% in 2015 and soared 489.04% in 2019, its largest moves.
- Tracing XOMA's Net Equity Issued and Repurchased over 5 years: stood at -$189000.0 in 2015, then surged by 106.35% to $12000.0 in 2016, then slumped by 541.67% to -$53000.0 in 2017, then jumped by 7141.51% to $3.7 million in 2018, then soared by 489.04% to $22.0 million in 2019.
- Business Quant data shows XOMA's Net Equity Issued and Repurchased at $22.0 million in Q4 2019, $3.7 million in Q4 2018, and $22000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 21.98 Mn |
| Dec 31, 2019 | 21.98 Mn |
| Dec 31, 2018 | 3.73 Mn |
| Dec 31, 2018 | 3.73 Mn |
| Jun 30, 2018 | 22,000.00 |
| Jun 30, 2018 | 22,000.00 |
| Mar 31, 2018 | 2.31 Mn |
| Mar 31, 2018 | 2.31 Mn |
| Sep 30, 2017 | -53,000.00 |
| Sep 30, 2017 | -53,000.00 |
| Mar 31, 2017 | 20.07 Mn |
| Mar 31, 2017 | 20.07 Mn |
| Dec 31, 2016 | 12,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Dec 31, 2015 | -189,000.00 |
| Dec 31, 2015 | -189,000.00 |
| Sep 30, 2015 | 149,000.00 |
| Sep 30, 2015 | 149,000.00 |
| Jun 30, 2015 | 77,000.00 |
| Jun 30, 2015 | 77,000.00 |